Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NUEDEXTA for PBA in Nursing Home Patients
NCT02496039Phase 4Terminated
- Sponsor
- Avanir Pharmaceuticals
- Start
- Sep 2015
- Primary completion
- May 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dextromethorphan + quinidine in pseudobulbar affect (PBA), sponsored by Avanir Pharmaceuticals. Started Sep 2015; status: terminated.
02
Drugs
dextromethorphan + quinidine
03
Conditions
pseudobulbar affect (PBA)
Beyond the preview
Go deeper on NCT02496039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496039.